VanEck Associates’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15M | Buy |
26,710
+785
| +3% | +$503K | 0.01% | 492 |
|
|
2025
Q4 | $17.5M | Buy |
25,925
+1,824
| +8% | +$1.24M | 0.01% | 423 |
|
|
2025
Q3 | $15.4M | Buy |
24,101
+237
| +1% | +$144K | 0.01% | 420 |
|
|
2025
Q2 | $12.8M | Sell |
23,864
-1,483
| -6% | -$709K | 0.01% | 417 |
|
|
2025
Q1 | $10.6M | Buy |
25,347
+655
| +3% | +$284K | 0.01% | 460 |
|
|
2024
Q4 | $10.2M | Sell |
24,692
-441
| -2% | -$193K | 0.01% | 464 |
|
|
2024
Q3 | $11.5M | Buy |
25,133
+2,367
| +10% | +$1.15M | 0.01% | 412 |
|
|
2024
Q2 | $11.1M | Buy |
22,766
+5,753
| +34% | +$2.89M | 0.02% | 393 |
|
|
2024
Q1 | $9.19M | Buy |
17,013
+720
| +4% | +$393K | 0.01% | 422 |
|
|
2023
Q4 | $9.04M | Buy |
16,293
+2,306
| +16% | +$1.08M | 0.02% | 395 |
|
|
2023
Q3 | $6.12M | Buy |
13,987
+276
| +2% | +$138K | 0.01% | 454 |
|
|
2023
Q2 | $6.89M | Sell |
13,711
-1,547
| -10% | -$741K | 0.02% | 426 |
|
|
2023
Q1 | $7.63M | Buy |
15,258
+2,625
| +21% | +$1.26M | 0.02% | 396 |
|
|
2022
Q4 | $5.15M | Sell |
12,633
-90
| -0.7% | -$34.9K | 0.01% | 456 |
|
|
2022
Q3 | $4.14M | Buy |
12,723
+737
| +6% | +$271K | 0.01% | 474 |
|
|
2022
Q2 | $4.2M | Sell |
11,986
-180,080
| -94% | -$73.4M | 0.01% | 500 |
|
|
2022
Q1 | $105M | Buy |
192,066
+59,810
| +45% | +$31.5M | 0.22% | 114 |
|
|
2021
Q4 | $87.1M | Buy |
132,256
+15,518
| +13% | +$9.74M | 0.2% | 119 |
|
|
2021
Q3 | $72.6M | Sell |
116,738
-32,019
| -22% | -$21.5M | 0.18% | 134 |
|
|
2021
Q2 | $93.9M | Sell |
148,757
-2,521
| -2% | -$1.39M | 0.22% | 118 |
|
|
2021
Q1 | $74M | Buy |
151,278
+38,356
| +34% | +$19.2M | 0.2% | 123 |
|
|
2020
Q4 | $56.4M | Buy |
112,922
+5,275
| +5% | +$2.36M | 0.16% | 125 |
|
|
2020
Q3 | $42.3M | Sell |
107,647
-3,830
| -3% | -$1.42M | 0.13% | 128 |
|
|
2020
Q2 | $36.8M | Sell |
111,477
-17,548
| -14% | -$5.08M | 0.13% | 132 |
|
|
2020
Q1 | $31.3M | Sell |
129,025
-11,267
| -8% | -$2.94M | 0.16% | 116 |
|
|
2019
Q4 | $36.6M | Buy |
140,292
+5,340
| +4% | +$1.41M | 0.14% | 129 |
|
|
2019
Q3 | $36.7M | Buy |
134,952
+990
| +0.7% | +$275K | 0.17% | 114 |
|
|
2019
Q2 | $36.9M | Sell |
133,962
-42,549
| -24% | -$10.5M | 0.18% | 124 |
|
|
2019
Q1 | $39.5M | Buy |
176,511
+481
| +0.3% | +$99.3K | 0.19% | 115 |
|
|
2018
Q4 | $32.7M | Buy |
176,030
+3,654
| +2% | +$749K | 0.16% | 118 |
|
|
2018
Q3 | $43M | Sell |
172,376
-7,328
| -4% | -$1.78M | 0.21% | 110 |
|
|
2018
Q2 | $39.2M | Buy |
179,704
+6,227
| +4% | +$1.28M | 0.18% | 120 |
|
|
2018
Q1 | $33.2M | Buy |
173,477
+13,630
| +9% | +$2.52M | 0.17% | 126 |
|
|
2017
Q4 | $25M | Sell |
159,847
-2,503
| -2% | -$394K | 0.12% | 159 |
|
|
2017
Q3 | $25.2M | Buy |
162,350
+4,220
| +3% | +$667K | 0.13% | 154 |
|
|
2017
Q2 | $25.5M | Sell |
158,130
-4,268
| -3% | -$693K | 0.14% | 133 |
|
|
2017
Q1 | $25.1M | Sell |
162,398
-18,197
| -10% | -$2.51M | 0.11% | 152 |
|
|
2016
Q4 | $21.2M | Buy |
180,595
+8,165
| +5% | +$932K | 0.11% | 146 |
|
|
2016
Q3 | $19.4M | Sell |
172,430
-5,279
| -3% | -$556K | 0.09% | 142 |
|
|
2016
Q2 | $16.5M | Buy |
177,709
+11,302
| +7% | +$971K | 0.08% | 150 |
|
|
2016
Q1 | $13M | Sell |
166,407
-585
| -0.4% | -$42.1K | 0.09% | 149 |
|
|
2015
Q4 | $12.2M | Sell |
166,992
-30,465
| -15% | -$2.17M | 0.1% | 166 |
|
|
2015
Q3 | $14.7M | Sell |
197,457
-47,622
| -19% | -$3.41M | 0.11% | 155 |
|
|
2015
Q2 | $15.7M | Buy |
245,079
+21,155
| +9% | +$1.46M | 0.09% | 175 |
|
|
2015
Q1 | $17.3M | Buy |
223,924
+1,280
| +0.6% | +$99.6K | 0.1% | 157 |
|
|
2014
Q4 | $16.5M | Sell |
222,644
-40,242
| -15% | -$2.82M | 0.1% | 154 |
|
|
2014
Q3 | $15.5M | Sell |
262,886
-58,298
| -18% | -$3.69M | 0.08% | 171 |
|
|
2014
Q2 | $21.4M | Sell |
321,184
-97,984
| -23% | -$6.23M | 0.1% | 139 |
|
|
2014
Q1 | $25.4M | Sell |
419,168
-385,054
| -48% | -$22.9M | 0.13% | 129 |
|
|
2013
Q4 | $42.8M | Buy |
+804,222
| New | +$42.3M | 0.22% | 90 |
|
Other funds holding IDXX
VCM
VPM
VanEck Associates's IDXX Position: Q1 2026 in Review
VanEck Associates increased its Idexx Laboratories (IDXX) stake by 3% in Q1 2026, buying an estimated $503K and bringing the position to 26,710 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #492.
VanEck Associates first reported a position in IDXX in Q4 2013 and has held it in 50 quarters since. The position peaked at $105M in Q1 2022. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- VanEck Associates held 26,710 shares of Idexx Laboratories worth $15M as of Q1 2026.
- VanEck Associates bought 785 Idexx Laboratories shares in Q1 2026, an estimated $503K.
- Idexx Laboratories made up 0.01% of VanEck Associates's portfolio in Q1 2026, its #492 holding.
- VanEck Associates first reported a position in Idexx Laboratories in Q4 2013 and has held it in 50 quarters since.
- VanEck Associates's Idexx Laboratories position peaked at $105M in Q1 2022.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.